Release No 46 2024 To Nasdaq Copenhagen

WEB Report on the first half year of 2024 for ROCKWOOL AS

Release no 46 2024 to Nasdaq Copenhagen

Volume growth efficient operations yield strong H1 and Q2 2024 sales and earnings

Highlights

• Net sales increased 25% to EUR 1,651 million (Q1-Q2 2024: 21%) driven by continued strong demand and price increases in all regions and segments.
• Operating profit increased 17% to EUR 261 million (Q1-Q2 2024: 21%) despite increased raw material and energy costs.
• Earnings per share increased 26% to EUR 1.06 (Q1-Q2 2024: 27%).
• Return on invested capital (ROIC) increased to 20% (Q1-Q2 2024: 19%).
• The Board of Directors proposes an interim dividend of DKK 10.80 per share (EUR 1.44) to be paid in August 2024.

Outlook

The global macroeconomic outlook remains uncertain, with high inflation, rising interest rates, and geopolitical tensions. Despite these challenges, ROCKWOOL expects continued growth in demand for its products and services in the coming quarters.

ROCKWOOL is well-positioned to meet this demand with its strong market position, global footprint, and commitment to innovation.

Upcoming dividend of 1080 per share

The ROCKWOOL Board of Directors has proposed an interim dividend of DKK 10.80 per share (EUR 1.44) to be paid in August 2024.

The dividend is subject to approval by ROCKWOOL's shareholders at the company's Annual General Meeting on May 11, 2024.

Global Gate Capital acquired Allianz operations in Lebanon from Allianz SE

Global Gate Capital, a leading private investment firm, has acquired Allianz operations in Lebanon from Allianz SE, one of the world's largest insurance companies.

The acquisition includes Allianz's life and non-life insurance businesses in Lebanon, which have a combined market share of approximately 10%.

Global Gate Capital plans to invest in the growth of Allianz's Lebanese operations and expand its product offerings.

XTRAALV. Yield Growth-Tochter Flourish Mushroom Labs erwirbt Technologierechte und meldet Patent zum Schutz einer..

XTRAALV.'s Yield Growth-Tochter Flourish Mushroom Labs hat die exklusiven Technologierechte zur Herstellung von Mykoprotein auf Basis von Pilzen erworben.

Das Unternehmen hat außerdem ein Patent zum Schutz seiner Technologie angemeldet.

Mykoprotein ist eine nachhaltige Proteinquelle, die als Fleischersatz verwendet werden kann.

Flourish Mushroom Labs plant, seine Technologie zur Herstellung von Mykoprotein in großem Maßstab zu nutzen und das Produkt an Lebensmittelhersteller zu verkaufen.